Mitsubishi UFJ Financial Group
8306
Nippon Telegraph & Telephone
9432
Metaplanet
3350
4
Mitsubishi Heavy Industries
7011
5
Toyota Motor
7203
JP Stock MarketDetailed Quotes
4564 OncoTherapy Science
- 21
- 00.00%
20min DelayMarket to Open Apr 7 15:30 JST
5.70BMarket Cap-3.47P/E (Static)
0High0Low0Volume0Open21Pre Close0.00Turnover6452wk High0.00%Turnover Ratio271.64MShares1552wk Low-4.81EPS TTM4.99BFloat Cap863Historical HighLossP/E (Static)237.68MShs Float15Historical Low-6.05EPS LYR0.00%Amplitude--Dividend TTM5.70P/B100Lot Size--Div YieldTTM
OncoTherapy Science Key Stats
EPS
According to the latest financial report of OncoTherapy Science, the latest earnings per share (TTM) for the company is -1.38. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about OncoTherapy Science's free cash flow? The latest report shows it as -136.50M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of OncoTherapy Science shows that the company's current ratio is 3.55, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of OncoTherapy Science, the quick ratio is 2.71, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of OncoTherapy Science? The latest ROE figure is -59.58%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of OncoTherapy Science, the total asset return on investment (ROA) is -33.45%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check OncoTherapy Science's latest financial report to see how their gross margin is doing - currently at -26.98%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of OncoTherapy Science, the net profit margin is -208.73%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...